iScience (Mar 2023)

PPT1 regulation of HSP90α depalmitoylation participates in the pathogenesis of hyperandrogenism

  • Tongmin Xue,
  • Shanmeizi Zhao,
  • Hong Zhang,
  • Ting Tang,
  • Lu Zheng,
  • Jun Jing,
  • Xie Ge,
  • Rujun Ma,
  • Jinzhao Ma,
  • Xiaoyan Ren,
  • Kadiliya Jueraitetibaike,
  • Zhigang Guo,
  • Li Chen,
  • Bing Yao

Journal volume & issue
Vol. 26, no. 3
p. 106131

Abstract

Read online

Summary: Ovarian granulosa cells (GCs) in the follicle are the important mediator of steroidogenesis and foster oocyte maturation. Evidences suggested that the function of GCs could be regulated by S-palmitoylation. However, the role of S-palmitoylation of GCs in ovarian hyperandrogenism remains elusive. Here, we demonstrated that the protein from GCs in ovarian hyperandrogenism phenotype mouse group exhibits lower palmitoylation level compared with that in the control group. Using S-palmitoylation-enriched quantitative proteomics, we identified heat shock protein isoform α (HSP90α) with lower S-palmitoylation levels in ovarian hyperandrogenism phenotype group. Mechanistically, S-palmitoylation of HSP90α modulates the conversion of androgen to estrogens via the androgen receptor (AR) signalling pathway, and its level is regulated by PPT1. Targeting AR signaling by using dipyridamole attenuated ovarian hyperandrogenism symptoms. Our data help elucidate ovarian hyperandrogenism from perspective of protein modification and provide new evidence showing that HSP90α S-palmitoylation modification might be a potential pharmacological target for ovarian hyperandrogenism treatment.

Keywords